Both FDA-regulated and CE-in vitro diagnostic (IVD) marked, the NextSeq 550Dx instrument enables clinical laboratories to develop and perform a wide range of applications, from NGS IVD assays using targeted panels, to clinical research applications that include methods from targeted panels to whole genomes.

Image Credit: Illumina, Inc

Flexibility of dual operating modes

Work within a regulated sequencing workflow for developing diagnostic tests and leveraging future NGS IVD tests in the pipeline while retaining the flexibility to work in a research environment and use the full range of Illumina sequencing methods for a wide range of applications.

NextSeq™ 550Dx sequencer

Image Credit: Illumina, Inc

Consistency of a clinical instrument

The instrument and sequencing reagents are CE-marked and regulated by the FDA, developed under design control principles, manufactured under Current Good Manufacturing Practices (cGMPs), and verified for consistent assay performance.

For In Vitro Diagnostic Use. Not available in all regions and countries.


Other Equipment by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.